Germany's Controversial New Unit Puts Pharmacy Licenses Under a Microscope
Germany has launched a new special unit called puppI to oversee pharmacy licenses and qualifications. The group is tasked with ensuring fairness and speed in processing credentials, but its methods have raised concerns. From high-tech surveillance during exams to digging into decades-old records, the unit's approach is under scrutiny.
The unit's work extends far beyond routine checks. During oral exams, biometric monitoring tracks candidates' reactions for signs of deceit. Written tests and state board examinations are also under surveillance, with drones and advanced equipment recording every moment. Even after exams, recordings are analysed second by second.
puppI's investigations reach back years, with employee Wolfgang currently reviewing PTA training diaries from 1995 for possible plagiarism. One case involved foreign pharmacist Fatma Balla, who faced suspicion of fraud over a missing date on an interim certificate. Meanwhile, pharmacist Professor Dr. Frank Leimkugel was ordered to repay €70,000 following an audit.
Despite its rigorous approach, no legal action—such as fines, criminal charges, or pharmacy closures—has resulted from puppI's findings so far. A separate ruling by Germany's Federal Social Court clarified that pharmacies can bill for the smallest full package of a medicinal product in compounded prescriptions.
puppI operates from previously unused government offices, reviewing both current and historical documents. While its work has sparked debate among professionals, no formal penalties have yet been imposed. The unit's long-term impact on pharmacy regulation remains to be seen.
